Mechanical cardiac support 2000: Current applications and future trial design

Journal of Heart and Lung Transplantation

Volumn 20, Issue 1, 2001, Pages 1-38

  Stevenson, Lynne Warner ^a   Kormos, Robert L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIGITALIS GLYCOSIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ENALAPRIL; FUROSEMIDE; HYDRALAZINE; INOTROPIC AGENT; NITROPRUSSIDE SODIUM; STREPTOKINASE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ARTIFICIAL HEART; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONFERENCE PAPER; DEVICE; EXTRACORPOREAL CIRCULATION; HEART ASSIST DEVICE; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART TRANSPLANTATION; HEART VALVE PROSTHESIS; HUMAN; IMPLANTATION; MEDICAL ETHICS; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVASCULARIZATION; RISK;

ASSISTED CIRCULATION; CLINICAL TRIALS; EQUIPMENT SAFETY; ETHICS, MEDICAL; HEART FAILURE, CONGESTIVE; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES;

EID: 0035140995     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)01099-8     Document Type: Conference Paper

References (111)

1. Device Selection
2. Extracorporeal support; centrifugal pumps
3. Extracorporeal support; the ABIOMED BVS 5000
4. Clinical experience with 111 thoratec ventricular assist devices
5. Improved survival rates support left ventricular assist device implantation early after myocardial infarction
6. Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance
7. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device
8. Worldwide experience with the TCI HeartMate system; issues and future perspective
9. The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant; a retrospective multi-centre study
10. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation
11. Factors influencing HLA sensitization in implantable LVAD recipients
12. The REMATCH trial; rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
13. Measurement of health state utilities for economic appraisal
14. Evolving concepts of heart failure; cooling furnace, malfunctioning pump, enlarging muscle-Part I
15. Evolving concepts of heart failure; cooling furnace, malfunctioning pump, enlarging muscle. Part II: Hypertrophy and dilatation of the failing heart
16. Chronic heart failure management
17. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure; results of the PROVED trial. PROVED Investigative Group
18. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study
19. The effect of digoxin on mortality and morbidity in patients with heart failure
20. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure
21. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina
22. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans' Administration Cooperative Study
23. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
24. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
25. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
26. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival And Ventricular Enlargement trial. The SAVE Investigators
27. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group
28. Extracorporeal assistance to the circulation and intraaortic balloon pumping
29. Results of coronary artery surgery in patients with poor left ventricular function (CASS)
30. Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study
31. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study
32. Cardiomyoplasty-Skeletal Muscle Assist Randomized Trial (C-SMART); six month results
33. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock
34. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH
35. When is heart failure a surgical disease?
36. The Registry of the International Society for Heart and Lung Transplantation; sixteenth official report-1999
37. The use of APACHE II scores to select candidates for left ventricular assist device placement
38. APACHE II score and mortality in respiratory failure due to cardiogenic pulmonary edema
39. APACHE II, data accuracy and outcome prediction
40. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators
41. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
42. Pretransplantation risk factors for death after heart transplantation; a multiinstitutional study. The Transplant Cardiologists Research Database Group
43. A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients; from CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable Defibrillators
44. Univentricular versus biventricular assist device support
45. Circulatory support for myocardial infarction with ventricular arrhythmias
46. Control of refractory ventricular tachycardia with biventricular assist devices
47. Management of recurrent ventricular tachycardia with ventricular assist device placement
48. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation
49. Heart transplant coronary artery disease detected by coronary angiography; a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database
50. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy
51. Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events
52. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices
53. 100 long-term implantable left ventricular assist devices; the Columbia Presbyterian interim experience
54. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation
55. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion
56. Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support
57. Selection criteria for placement of left ventricular assist devices
58. Quality of life with an implanted left ventricular assist device
59. Target heart failure populations for newer therapies
60. Measuring quality of life for patients with terminal illness; the Missoula-VITAS quality of life index
61. The last six months of life for patients with congestive heart failure
62. The controlled randomized clinical trial in the evaluation of cancer treatment-the dilemma and alternative trial design
63. Equipoise and the ethics of clinical research
64. Of mice but not men. Problems of the randomized clinical trial
65. Clinical trials-are they ethical?
66. How to resolve an ethical dilemma concerning randomized clinical trials
67. Outpatient continuous inotropic therapy with end stage heart failure; palliative or life-prolonging?
68. Ethical factors in the allocation of experimental medical therapies; the chronic left ventricular assist system
69. Understanding controlled trials. What is a patient preference trial?
70. Incorporating patient preferences into randomized trials
71. Patient preferences and randomised clinical trials
72. Are randomized controlled trials controlled? Patient preferences and unblind trials
73. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases
74. Early ambulation after 5 French diagnostic cardiac catheterization; results of a multicenter trial
75. A comparison of observational studies and randomized, controlled trials
76. Randomized, controlled trials, observational studies, and the hierarchy of research designs
77. Rationale and design of the OPTIME CHF trial; outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure
78. Clinical and prophylactic trials with assured new treatment for those at greater risk; I. A design proposal
79. Long-term mechanical circulatory support system reliability recommendation; American Society for Artificial Internal Organs and The Society of Thoracic Surgeons: long-term mechanical circulatory support system reliability recommendation
80. Development of the Nimbus/Pittsburgh axial flow left ventricular assist system
81. Durability testing of components for the Jarvik 2000 completely implantable axial flow left ventricular assist device
82. Miniature axial flow pump for ventricular assistance in children and small adults
83. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation
84. AB-180 circulatory support system; summary of development and phase I clinical trial
85. Portable pneumatic biventricular driver for the Thoratec ventricular assist device
86. First clinical use of the Thoratec TLC-II portable VAD driver in ambulatory and patient discharge settings
87. A completely implanted left ventricular assist device. Chronic in vivo testing
88. An atrial hydraulic shunt in a total artificial heart. A balance mechanism for the bronchial shunt